Xponance is Targeting the ‘Unloved Spaces Within Private Markets’
“If you look at where allocation dollars are going versus where alpha is, they're not in the same place,” says Tina Byles Williams.
Recent Articles
Are Evergreen Funds Too Good to be True?
The NYSE debut of Bluerock’s BPRE at a huge discount to NAV illustrates one of the strategy’s biggest problems.
Don’t Want Crypto in Your Portfolio? You Might Need to Look Closer at Your Equity Funds.
MPI has found several non-crypto funds show signs of at least indirect exposure to bitcoin, which can lead “to a roller-coaster ride.”
James Comtois
December 17, 2025
More Articles
ETFs: Growing Institutional Adoption
Sponsored by Invesco
